EirGenix (TPE:6589) Inventory Turnover: 0.46 (As of Dec. 2025)

What is EirGenix Inventory Turnover?

EirGenix TPE:6589 58 Inventory Turnover is 0.46 as of Dec. 2025. GuruFocus rates TPE:6589 with a GF Score™ of 58/100 and a GF Value™ of NT$92.83 (Possible Value Trap). The stock has 6 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. EirGenix's Cost of Goods Sold for the three months ended in Dec. 2025 was NT$238 Mil. EirGenix's Average Total Inventories for the quarter that ended in Dec. 2025 was NT$516 Mil. EirGenix's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.46.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. EirGenix's Days Inventory for the three months ended in Dec. 2025 was 197.94.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. EirGenix's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 1.42.

EirGenix (TPE:6589) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

EirGenix's Days Inventory for the three months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	516.04	/	237.889	*	365 / 4
	=	197.94

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

EirGenix's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	516.04	/	363.622
	=	1.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

EirGenix Inventory Turnover Related Terms

EirGenix Inventory Turnover Historical Data

* Premium members only.

The historical data trend for EirGenix's Inventory Turnover can be seen below:

EirGenix Inventory Turnover Chart

EirGenix Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

2.10

1.26

1.11

1.28

1.55

EirGenix Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															0.36	0.29	0.37	0.36	0.46

58GF Score

EirGenix Inc TPE:6589

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

EirGenix Inventory Turnover Calculation

EirGenix's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	811.327	/ (	(552.088	+	492.872)	/	2 )
=	811.327	/	522.48
=	1.55

EirGenix's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Sep. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	237.889	/ (	(539.208	+	492.872)	/	2 )
=	237.889	/	516.04
=	0.46

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.46 mean?

EirGenix (TPE:6589) has a Inventory Turnover of 0.46 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on EirGenix and its competitors.

Is EirGenix's Inventory Turnover too high?

EirGenix's current Inventory Turnover is 0.46. Overall, EirGenix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does EirGenix's Inventory Turnover compare to VRTX and REGN?

EirGenix's Inventory Turnover of 0.46 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on EirGenix and its competitors. EirGenix's current Inventory Turnover is 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is EirGenix stock overvalued right now?

Based on GuruFocus' analysis, EirGenix (TPE:6589) is currently considered Possible Value Trap. The stock's GF Value™ is NT$92.83, compared to a current price of NT$48.25 — trading 48% below its estimated fair value. The current Inventory Turnover is 0.46. EirGenix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For EirGenix (TPE:6589), the current Inventory Turnover is 0.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EirGenix (TPE:6589) Overvalued in 2026?

Based on GuruFocus' analysis, EirGenix stock appears to be undervalued. The current stock price of NT$48.25 is trading 48% below its estimated GF Value™ of NT$92.83. GuruFocus considers EirGenix to be Possible Value Trap.

Key valuation signals for TPE:6589:

Inventory Turnover: 0.46
GF Value™: NT$92.83 vs. price of NT$48.25 (48% below fair value)
GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the TPE:6589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EirGenix Business Description

Industry Healthcare Biotechnology

Comparable Companies ROCO:6547 ROCO:6712 TPE:4169 ROCO:6748 ROCO:6535 ROCO:4147 TPE:6550 TPE:6541 ROCO:6891 ROCO:6945 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180

Website https://www.eirgenix.com

EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST. The revenue is derived from biopharmaceutical contract development and manufacturing services, sales of authorization and cooperative development, and sales of goods. Geographically, it operates in Japan, Taiwan, USA and Canada, Mainland China, Hong Kong, and Macao, and Europe, Others.

58GF Score

Get the complete analysis for TPE:6589

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$48.25

Price

NT$92.83

GF Value

View TPE:6589 Analysis

See Inventory Turnover data for all stocks →